{"id":537,"date":"2026-06-07T23:41:36","date_gmt":"2026-06-07T23:41:36","guid":{"rendered":"https:\/\/biosynlab.com\/?post_type=product&p=537"},"modified":"2026-06-23T08:21:25","modified_gmt":"2026-06-23T08:21:25","slug":"buy-gw-0742-capsules","status":"publish","type":"product","link":"https:\/\/www.biosynlab.com\/?product=buy-gw-0742-capsules","title":{"rendered":"buy GW-0742 capsules"},"content":{"rendered":"

Premium GW-0742 Capsules: Industrial Grade PPAR\u03b4 Agonist for Advanced Research<\/h1>\n

 <\/p>\n

\u00a0PRODUCT SPECIFICATIONS TABLE<\/strong><\/h2>\n

 <\/p>\n

\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Attribute<\/th>\nSpecification<\/th>\n<\/tr>\n<\/thead>\n
Brand<\/strong><\/td>\nbiosynlab<\/td>\n<\/tr>\n
Product Name<\/strong><\/td>\nGW-0742 Capsules<\/td>\n<\/tr>\n
IUPAC Name<\/strong><\/td>\n2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid<\/td>\n<\/tr>\n
Common Names<\/strong><\/td>\nGW-0742, GW610742, PPAR\u03b4 agonist<\/td>\n<\/tr>\n
CAS Number<\/strong><\/td>\n317318-84-6<\/td>\n<\/tr>\n
Molecular Formula<\/strong><\/td>\nC\u2082\u2081H\u2081\u2087F\u2084NO\u2083S\u2082<\/td>\n<\/tr>\n
Molecular Weight<\/strong><\/td>\n471.48 g\/mol<\/td>\n<\/tr>\n
Form<\/strong><\/td>\nGelatin Capsules<\/td>\n<\/tr>\n
Capsule Dosage<\/strong><\/td>\n10mg per capsule<\/td>\n<\/tr>\n
Pack Size<\/strong><\/td>\n30 capsules, 60 capsules, 90 capsules<\/td>\n<\/tr>\n
Purity<\/strong><\/td>\n\u226598.5% (HPLC)<\/td>\n<\/tr>\n
Chemical Class<\/strong><\/td>\nPPAR\u03b4 Agonist \/ Metabolic Modulator<\/td>\n<\/tr>\n
Appearance<\/strong><\/td>\nWhite powder in clear gelatin capsules<\/td>\n<\/tr>\n
Storage<\/strong><\/td>\n2-8\u00b0C, desiccated, light-protected<\/td>\n<\/tr>\n
Packaging<\/strong><\/td>\nAmber pharmaceutical bottle with desiccant<\/td>\n<\/tr>\n
Shelf Life<\/strong><\/td>\n36 months when stored properly<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n

<\/h2>\n

Premium GW-0742 Capsules \u2013 Laboratory Grade PPAR\u03b4 Agonist<\/strong><\/h3>\n

biosynlab<\/strong>\u00a0delivers pharmaceutical-grade\u00a0GW-0742 Capsules<\/strong>\u00a0<\/a>for sophisticated scientific research and analytical applications. As a premier supplier of PPAR\u03b4 agonists and metabolic modulators to laboratories across the\u00a0USA, United Kingdom, and European Union<\/strong>, we provide researchers with precisely dosed, high-purity compounds essential for reproducible experimental protocols and cutting-edge metabolic research.<\/p>\n

Chemical Composition & Structure<\/strong><\/h4>\n

GW-0742<\/strong>\u00a0(systematic name:\u00a02-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid<\/strong>), also known as\u00a0GW610742<\/strong>, is a potent and highly selective PPAR\u03b4 (peroxisome proliferator-activated receptor delta) agonist developed by GlaxoSmithKline. This advanced compound features a unique chemical structure with a fluorinated phenyl-thiazole core linked via a methylsulfanyl bridge to a phenoxyacetic acid moiety. The molecular formula\u00a0C\u2082\u2081H\u2081\u2087F\u2084NO\u2083S\u2082<\/strong>\u00a0yields a molecular weight of 471.48 g\/mol.<\/p>\n

As a next-generation PPAR\u03b4 agonist, GW-0742<\/a> demonstrates exceptional selectivity for the PPAR\u03b4 subtype over PPAR\u03b1 and PPAR\u03b3, distinguishing it from earlier compounds. This selectivity profile has made it a compound of significant interest in research examining lipid metabolism, endurance capacity, and metabolic disorders.<\/p>\n

Capsule Advantages for Research<\/strong><\/h4>\n

Our\u00a010mg capsules<\/strong>\u00a0offer distinct advantages for laboratory workflows:<\/p>\n